Posts by University of Pennsylvania School of Medicine
Hormone drugs may disarm SARS-CoV-2 spike protein and stop COVID-19 progression
Hormone drugs that reduce androgen levels may help disarm the SARS-CoV-2 spike protein used to infect cells and stop the progression of severe COVID-19. …
Read Full ArticleOff-the-shelf immune drug shows promise in aggressive multiple myeloma
Teclistamab injection found to be safe and elicit responses in 74 percent of patients with relapsed/refractory multiple myeloma. …
Read Full ArticleMagnetic field and hydrogels could be used to grow new cartilage
New research shows that it’s possible to use a magnetic field and hydrogels to rebuild complex body tissues …
Read Full ArticleScientists engineer antimicrobial molecules from wasp venom
Scientists have engineered powerful new antimicrobial molecules from toxic proteins found in wasp venom. …
Read Full ArticleResearchers uncover epigenetic drivers for Alzheimer’s disease
New findings suggest that late-onset Alzheimer’s disease is driven by epigenetic changes — how and when certain genes are turned on and off — in the brain. …
Read Full ArticleMiddle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility
Middle-aged individuals born in the late 1960s and the 1970s may be in a perpetual state of H3N2 influenza virus susceptibility …
Read Full ArticleInvestigational drug stops toxic proteins in neurodegenerative diseases
A preclinical study finds that toxic proteins from the mutated C9orf72 gene stimulate TDP-43 clumping, a well-known hallmark of neurodegenerative diseases. …
Read Full ArticleActivating an estrogen receptor can stop pancreatic cancer cells from growing
Activating the G protein-coupled estrogen receptor (GPER) stops pancreatic cancer from growing and also makes tumors more visible to the immune system …
Read Full ArticleBlood test may help doctors catch pancreatic cancer early
Study shows liquid biopsy may be a viable option for both diagnosis and staging of pancreatic cancer. …
Read Full ArticlePARP inhibitor drugs can be ‘tuned’ for better killing of tumor cells
Cancer-killing “PARP inhibitor” drug that has struggled to show effectiveness in clinical trials can be structurally modified to greatly increase its power to kill tumor cells. …
Read Full Article